CPP ( DrugBank: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
76	下垂体性ゴナドトロピン分泌亢進症	6

76. 下垂体性ゴナドトロピン分泌亢進症

臨床試験数 : 29 / 薬物数 : 44 - (DrugBank : 14) / 標的遺伝子数 : 5 - 標的パスウェイ数 : 15

diseases per page:

Showing 1 to 6 of 6 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05341115 (ClinicalTrials.gov)	March 20, 2023	18/4/2022	A Study of Leuprolide Acetate Depot in Children With Central Precocious Puberty	An Open Label, Multicenter, Single-arm and Prospective Study to Assess the Efficacy and Safety of Le ...	Central Precocious Puberty	Drug: Leuprorelin Acetate Depot 3M	Takeda	NULL	Not yet recruiting	N/A	9 Years	All	80	Phase 4	China
2	ChiCTR2000034464	2020-09-01	2020-07-05	First Morning Voided Urinary Gonadotropin Measurements for the Early Screening, Diagnosis and Follow ...	First Morning Voided Urinary Gonadotropin Measurements for the Early Screening, Diagnosis and Follow ...	Central precocious puberty	Gold Standard:Clinical outcome by CPP diagnostic standards;Index test:morning urine GN;	Department of Pediatrics, Tongji Hospital of Tongji Medical College, Huazhong University of Science ...	NULL	Pending	6	12	Both	Target condition:400;Difficult condition:6000		China
3	NCT03695237 (ClinicalTrials.gov)	October 24, 2018	2/10/2018	A Study to Evaluate Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Leuprolide Acetate 4 ...	A Phase 3, Multicenter, Open-Label, Two-Part Study to Evaluate the Safety, Efficacy, Pharmacokinetic ...	Central Precocious Puberty (CPP)	Drug: Leuprolide Acetate (LA)	AbbVie	NULL	Active, not recruiting	2 Years	11 Years	All	45	Phase 3	United States;Puerto Rico
4	NCT02993926 (ClinicalTrials.gov)	June 24, 2017	13/12/2016	A Study to Assess the Safety and Efficacy of Enantone (Leuprorelin) in Central Precocious Puberty (C ...	An Observational, Retrospective Study to Evaluate the Long Term Safety and Effectiveness of Leuprore ...	Central Precocious Puberty	Drug: Enantone;Drug: GnRH agonist	Takeda	NULL	Completed	N/A	N/A	All	108		China
5	NCT02974270 (ClinicalTrials.gov)	June 2016	19/5/2016	Analysis of Body Mass Index in Central Precocious Puberty Patients Treated With Leuprolide Acetate	Analysis of Body Mass Index in Central Precocious Puberty(CPP) Patients Treated With Leuprolide Acet ...	Precocious Puberty, Central	Drug: Leuprolide	Kyungpook National University	NULL	Recruiting	N/A	9 Years	Both	100	Phase 4	Korea, Republic of
6	NCT00667446 (ClinicalTrials.gov)	December 2008	24/4/2008	Safety Extension Study Of Leuprolide Acetate (Lupron Depot) In The Treatment Of Central Precocious P ...	A 36 Month, Multi-Center, Open-Label Extension Study to Evaluate the Safety of Leuprolide Acetate 11 ...	Precocious;Leuprolide Acetate;Luteinizing Hormone (LH);Gonadotrophin-releasing Hormone Agonist (GnRH ...	Drug: Leuprolide Acetate 3 Month Depot	AbbVie (prior sponsor, Abbott)	NULL	Completed	N/A	N/A	All	72	Phase 3	United States;Puerto Rico

First Previous1Next Last